Meet ASPIRE: Galderma Rolls Out New Customer Loyalty Program
Galderma is rolling out a new loyalty program for both doctors and patients.
Tag: Galderma
All
PopularAll
Latest
Galderma Restylane Eyelight HA Filler Receives FDA Approval
Restylane Eyelight, an undereye hyaluronic acid (HA) dermal filler, is formulated with NASHA Technology for volume loss under the eyes.
All
Latest
New Wound Dressing Targets Recovery After Energy-Based Aesthetic Treatments
Set to debut in Europe, the dressing is made from biosynthetic cellulose and designed to reduce downtime and risk after procedures like microneedling and laser therapy.
Galderma Receives FDA Approval for New SCULPTRA Label, Offering More Options to Aesthetic Partners
Galderma announces the new label for SCULPTRA (injectable poly-L-lactic acid (PLLA)), the first and only FDA-approved PLLA facial injectable treatment that helps stimulate the skin’s own collagen production, to smooth facial wrinkles, such as smile lines.
Read More
Aesthetics Biomedical Inc Announces Perspectives Symposium
On the heels of Aesthetics Biomedical’s inaugural symposium launched in Phoenix (April 2021) comes the follow-up activation, Perspectives: The Evolution of Aesthetics, a boutique-style symposium is taking place in Orlando, Fla.
Read More
New MENTOR, Galderma Partnership Rewards Breast Implant Patients, and Practitioners
Doctors gain access to key insights about the products, utilizing business-building tools that encourage each patient’s aesthetic journey.
Read More
FDA Approves Restylane Contour
Galderma’s first and only product in the U.S. to use proprietary XpresHAn Technology for the cheeks is coming to practices this summer.
Read More
Galderma Launches Multichannel Medical Education Platform
Galderma announces the launch of its Galderma Excellence in Multichannel Medical Education (GEMME) platform with a four-part webinar series: “Unmasking Facial Skin & Dermatoses.”
Read More
COVID-19 Mask Wearing Could Be Worsening Rosacea
A recent survey conducted by Galderma suggests that the pandemic may impact rosacea patients, from worsening of signs and symptoms related to mask wearing, to reduced HCP consultations.
Read More
Latest FDA Approval Helps Galderma Expand a Growing Restylane Product Portfolio
According to reports, in 2020, online searches for chin enhancement products, like Restylane Defyne, increased by 185%.
Read More
New Galderma Face for Change Program Runs Through February
Partnerships with Dress for Success and the Skin Cancer Foundation provide an opportunity to give back, with each Dysport for injection treatment.
Read More
Galderma Releases Top-line Results from Phase 2 Clinical Dose-Escalating Study with Dysport (Azzalure)
Based on encouraging safety and long-term efficacy results of the Dysport study, and continued patient satisfaction, the company is evaluating future clinical studies.
Read More
Galderma To Present Five Abstracts in Support of Novel Aesthetics Solutions and Pipeline at ASDS 2020 Annual Meeting
Galderma announces the presentation of data from clinical trials of its aesthetic solutions and pipeline in five abstracts at the virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual Meeting.
Read MoreNestlé's Pharma Experiment Nears an End with $10B Skin Health Sale Talks
Just five years after Nestlé took full possession of dermatology specialist Galderma amid a pivot to pharma, the Swiss company is now in the final stage of bailing out of skin health as it refocuses on food and nutrition, FiercePharma reports.
Read MoreGalderma's ASPIRE Loyalty Program Reaches 1 Million Members
Galderma Laboratories LP announces that its ASPIRE Galderma Rewards program has reached the one million member milestone.
Read MoreZELTIQ Aesthetics and Galderma Announce US Partnership
Galderma and ZELTIQ® Aesthetics Inc are partnering up, effective immediately.
Read MoreEpiduo, Acne’s Newest Enemy, Hits Stores
Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% is now available in pharmacies nationwide and in Puerto Rico.
Read MoreFDA Approves Galderma’s Restylane Lyft for Cheek Augmentation
FDA Approves Restylane Lyft with lidocaine to correct age-related volume loss in the cheek area.
Read More